Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Alzinova carries out a 95 percent guaranteed rights issue of units of approximately SEK 50 million to finance the clinical development of ALZ-101

The Board of Directors of Alzinova AB (publ) ("Alzinova" or "the Company") has today, with the support of the authorization from the Annual General Meeting on 14 May 2020, decided to carry out a rights issue of units consisting of shares and warrants ("Units") with preferential rights for the Company's existing shareholders (the "Rights Issue"). The initial issue proceeds amount to approximately SEK 50 million. Upon full exercise of the warrants, the Company will receive an additional SEK 25-42 million (depending on the final exercise price and assuming full subscription). The Company has

First commercial scale manufacturing of Mangoral

Ascelia Pharma AB (publ) (ticker: ACE) (“Ascelia”) today announced that the company has reached a key achievement with the first commercial scale manufacturing of its lead compound Mangoral, currently in pivotal Phase 3 development. The commercial scale manufacturing is an important step towards market launch.The milestone was reached in close collaboration with the manufacturing partner Cambrex, based in Whippany, New Jersey, US. All quality and manufacturability requirements were met and reproduced for this full-scale manufacture. High-quality manufacturing is key to patient safety and an

Continued strong earnings development in NOTE despite a slightly weaker market during Q3

For a long time, NOTE has developed very positively with increased market shares, strong organic growth and gradually increased margins. For the third quarter, a continued positive earnings trend is expected. The operating margin for Q3 is estimated to amount to approximately 8.0%, which means a significant increase in margins compared with last year. The development is particularly strong in Sweden and Finland. However, demand in England and China is at a lower level, primarily as an effect of the current pandemic. Together with delays in some new customer projects, this contributes to

Obducat launch revolutionary technology enabling full industrialization of NIL

OBDUCAT AB (publ) subsidiary Obducat Technologies AB, a leading supplier of lithography solutions based on nanoimprint lithography (NIL), launches new technology enabling the final  step towards full industrialization of nanoimprint lithography. The technology has already been completed for Obducat's fully automated Sindre system, as well as for Eitre Large Substrate. For several years, Obducat has worked to establish a universal solution that eliminates the problem of compatibility between materials used in the imprint process. With the newly developed technology, Obducat can coat the

Notice of Extraordinary General Meeting in Sweco AB (publ)

Sweco AB will on September 22, 2020, publish the content of the notice of the Extraordinary General Meeting in the Official Gazette (Post- och Inrikes Tidningar) and on the company’s website. A note that the notice has been issued will at the same time be published in Svenska Dagbladet.  Due to the risk of spreading Covid-19 and the authorities’ regulations/guidance on avoiding gatherings of people, the Board of Directors has decided that the general meeting should be held without physical presence by inviting the shareholders to exercise their voting rights only by postal voting.

Read original

RLS Global presents data about ChloraSolv and its rapid response and high efficacy on biofilm

At the EWMA (European Wound Management Association) Conference in November, RLS will present data where our technology has been evaluated in an ex-vivo wound model with very exciting results on biofilm. The evaluation was carried out together with RISE, Research Institute of Sweden.Biofilm is challenging in Wound Management. Staphylococcus aureus and Pseudomonas aeruginosa are two common bacteria that form biofilms in chronic wounds. A biofilm is formed by a high number of bacteria that protect themselves through a secretion of a viscous barrier. One consequence of biofilm formation is that

Puurakentajat strengthens its position in the growing market for detached homes by acquiring Lahden Puurakentajat

Puurakentajat Group Oy, the Finnish expert in wood and Cross Laminated Timber (CLT) construction, has signed an agreement to acquire 100 % of Lahden Puurakentajat Oy. The acquisition enables Puurakentajat Pientalot Oy, part of Puurakentajat Group Oy, to offer private customers construction of cost-effective, ecological and high-quality solid wood detached homes. The acquisition also strengthens Puurakentajat’s expertise in CLT and Laminated Veneer Lumber -construction and expands the company's market position in the growing market for construction of solid wood homes. Lahden

Investor AB’s Nomination Committee for the 2021 Annual General Meeting

Investor AB’s Nomination Committee for the Annual General Meeting 2021 hasbeen appointed based on the ownership structure as of August 31, 2020.  The Nomination Committee consists of:Michael Treschow, Wallenberg FoundationsAnders Oscarsson, AMF and AMF FundsLars Isacsson, SEB FoundationRamsay Brufer, AlectaJacob Wallenberg, Chair of the Board of Investor AB Shareholders having appointed members to the Nomination Committee representapproximately 65 percent of the voting rights for all shares of Investor AB. The Annual General Meeting of Investor AB will be held on

Tikkurila Oyj – Managers’ Transactions

Tikkurila Oyj, Managers’ Transactions, 18 September 2020 at 09.15 a.m. (EEST) Tikkurila Oyj – Managers’ Transactions With reference to the EU Market Abuse Regulation, Tikkurila Oyj has received a notification from Oras Invest Oy of a transaction made on 15 September 2020. Detailed information about the transaction is given below. ____________________________________________ Person subject to the notification requirement Name: Oras Invest Oy Position: Closely associated person (X) Legal person (1): Person Discharging Managerial Responsibilities In Issuer Name:

2020 Bulkers Ltd. (2020) – Extended time charter for Bulk Shanghai

Hamilton, Bermuda, 18 September 2020, 2020 Bulkers has extended the time charter for Bulk Shanghai with ST Shipping, a fully owned subsidiary of Glencore for a period of 6-8 months from 4 October 2020. The vessel will from 4 October 2020 earn a fixed rate of USD 18,000 per day, gross, as well as share of the fuel savings generated from the scrubber. Magnus Halvorsen, CEO of 2020 Bulkers Management AS says: “We are pleased to further develop our good relationship with Glencore. The extended time charter for Bulk Shanghai secures cash flow through the first quarter of 2021 at a level

Optomed and AEYE Health to introduce a handheld AI fundus camera

Optomed and AEYE Health have agreed to enter clinical and commercial collaboration to introduce an AI fundus camera Aurora AEYE. The collaboration includes a clinical trial with the aim to receive U.S. Food and Drug Administration (FDA) approval for autonomous AI for retinal screening. Once the clinical trials are commenced and successfully completed, the Aurora AEYE will include Optomed’s handheld fundus camera Aurora and AEYE Health’s AI-based retinal screening system, that aims to provide analysis of the retina for diabetic retinopathy changes and receive diagnostic results within 60

Talouselämä is the first journalistic print publication in Finland to go carbon neutral

Alma Media Corporation            Press release 18 September 2020TALOUSELÄMÄ IS THE FIRST JOURNALISTIC PRINT PUBLICATION IN FINLAND TO GO CARBON NEUTRALThe largest financial magazine in the Nordic countries, Talouselämä, published by Alma Talent, will be Finland’s first journalistic print publication to turn carbon neutral on Friday, 25 September 2020. The carbon footprint from printing Talouselämä (11.7 tonnes of CO2-eq per issue on average) will be fully compensated in cooperation with PunaMusta printing house. The climate project related to the compensation is an afforestation

Notice of Extraordinary General Meeting of Husqvarna AB (publ)

The shareholders of Husqvarna AB (publ) are hereby invited to participate in the 2020 Extraordinary General Meeting (“EGM”), which will be held on Friday, October 23, 2020. In light of the continued COVID-19 pandemic, the EGM will be conducted pursuant to so called mail-in procedures, meaning that no shareholders will attend the EGM in person or through proxy. Instead, shareholders can participate in the EGM by voting and submitting questions in advance pursuant to the instructions described below.In order to participate in the EGM, a shareholder must 1. a. be registered in the

Rite Ventures has completed the acquisition of the shares in Qliro Group from Kinnevik

Press release, Stockholm, 18 September 2020 Qliro Group announced on June 11, 2020 that the company had been informed that its two largest shareholders, Kinnevik and Rite Ventures, had entered into an agreement meaning that Rite Ventures would acquire 36,021,945 shares in Qliro Group from Kinnevik. The transaction was conditional on approval from the Swedish Financial Supervisory Authority, which has now been announced. This means that the transaction now has been completed and that Rite Ventures is the largest shareholder in Qliro Group with 25.06 percent of the total number of shares

MATINS trial data presented at ESMO

Data from completed Part I of bexmarilimab MATINS trial presented at ESMO Virtual Congress 2020TURKU – FINLAND, 18 September 2020 – Faron Pharmaceuticals Ltd (“Faron”) (LON: FARN), the clinical stage biopharmaceutical company, today announces details from an oral presentation being held at the European Society of Medical Oncology (ESMO) Virtual Congress 2020, showcasing data from the Company’s ongoing MATINS trial to the scientific community. The ongoing phase I/II MATINS clinical trial is investigating the tolerability, safety and efficacy of bexmarilimab, Faron's wholly-owned novel

Karoliina Partanen, EVP, Communications, joins Kesko’s Group Management Board

Karoliina Partanen, M.Sc. (Soc.), has been appointed Executive Vice President in charge of Communications, Brand and Stakeholder Relations and a member of Kesko’s Group Management Board as of 1 October 2020. Partanen was appointed Kesko’s Senior Vice President, Communications and Identity in 2017, and between 2015 and 2017 she acted as Vice President, Communications for Kesko’s grocery trade division. Before joining Kesko, Partanen held various executive positions in communications and marketing at Metso Corporation. Further information: Matti Mettälä, EVP, Human Resources, Corporate

Aspire Global Reveals its Solid Strategy for Continued Profitable Growth

Today at its Capital Markets Day, Aspire Global  reveals its solid strategy for continued profitable growth. The objective is to grow in locally regulated markets and to double the number of licenses in five years. Aspire Global will continue its expansion in Europe and North America as well as to break into Latin America and Africa which will happen through the acquisition of the sportsbook provider BtoBet which was announced yesterday. The financial targets, set in December 2018, remain unchanged.The foundation for Aspire Global’s further success is the

New order for Svenska Aerogel Holding (publ) - positive response after technology development

The first order for Quartzene produced with the new production technology was received today from Barozzi Vernici, using Quartzene for insulating plasters.-   Very positive feedback from customers who have had the opportunity to evaluate Quartzene manufactured with our new technology. The material is easier to handle and allows a higher degree of addition levels, which further increases the insulation effect in the final product, explains Sara Wengström, Account Manager at Svenska Aerogel. [Account Manager] The product Thermo-Line® won an innovation competition in the Netherlands in

Redsense presents on Aktiedagen Digitalt

Redsense Medical AB will participate in the virtual investor meet Aktiedagen Digitalt. Patrik Byhmer, CEO, will present the company and its operations at 10:30 a.m. on Monday, September 21, 2020. The presentation will be held in Swedish. To view the list of speakers and find more information about the event, please visit https://www.aktiespararna.se/aktiviteter/aktiedagen-digitalt-21-september-2020. “We welcome anyone interested in the company, our technology and our development strategy to attend this event. Redsense Medical is in a very exciting phase at the moment, with a resilient

OXE Marine AB (publ) and Evoy AS assessing the potential of a high-powered electric outboard

OXE Marine AB (publ) (the “Company”) has today entered into a cooperation agreement with Evoy AS, an electric marine propulsion company based in Norway, to assess the technical and market viability of a high powered electric outboard using Evoy’s proprietary electrical propulsion system and the Company’s patented lower leg to deliver a high powered, high torque application.The Company has entered into a cooperation agreement with Evoy AS to assess the technical and market viability of a high-powered electric outboard using the Company’s patented lower leg together with Evoy’s electrical

Ericsson accelerates 5G for Enterprise with acquisition of Cradlepoint

· Ericsson acquires the market-leader for Wireless Edge WAN solutions for an enterprise value of USD 1.1 b. · Acquisition complements Ericsson’s enterprise offerings and creates valuable new revenue streams for customers · Transaction expected to close during Q4 2020, subject to merger clearance and other closing conditionsEricsson (NASDAQ: ERIC) has agreed to acquire Cradlepoint, the US-based market leader in Wireless Edge WAN 4G and 5G Enterprise solutions. The investment is key to Ericsson’s ongoing strategy of capturing market share in the rapidly expanding 5G Enterprise space.

Autumn brings delicious new Valio products and even less plastic

New Valio products for the Finnish market area are here! The autumn everyday food season starts with an appetising vegetarian steak. The hunger for snacks is satisfied with organic foods or without added sugar, and a family favourite cheese is now available in a handy snack size. The environment benefits by a reduced amount of plastic and increased use of recycled plastic in Valio PROfeel®  protein snacks and sliced cheese packaging.Valio MiFU® vegetarian steaks are succulent and can be shaped Valio MiFU® steaks are a 100% plant-based novelty for those in search of an easy, tasty meal!

Announcement of final exchange ratio in relation to the contemplated merger with Aker Solutions ASA

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. 18 September 2020 – Reference is made to the previous stock exchange announcements made by Kværner ASA (“Kvaerner”) regarding the contemplated merger with Aker Solutions ASA (“Aker Solutions”) as further set out in the merger plan dated 17 July 2020

Aker Solutions ASA: Announcement of Final Exchange Ratio in Relation to the Contemplated Merger With Kværner ASA

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. September 18, 2020 - Reference is made to the previous stock exchange announcements made by Aker Solutions ASA (“Aker Solutions”) regarding the contemplated merger with Kværner ASA (“Kvaerner”) as further set out in the merger plan dated July 17,

There are no items matching the current filter
There are no more items matching the current filter
Back to top